白细胞介素-4与白细胞介素-10融合蛋白在体外和体内防止血液诱导的软骨损伤
本研究评估IL4-10融合蛋白对血液诱导关节损伤的保护作用。体外实验中,融合蛋白呈剂量依赖性防止血液诱导的软骨损伤,10 ng/mL可完全阻断单核/巨噬细胞产生IL-1β和IL-6。在血友病A小鼠中,关节腔内注射融合蛋白可减轻反复关节出血后的软骨损伤,但滑膜炎症几乎未受影响。
要点
- 体外融合蛋白呈剂量依赖性防止血液诱导的软骨损伤,效果与单独细胞因子联合相当。
- 10 ng/mL融合蛋白完全阻断全血培养中单核/巨噬细胞产生IL-1β和IL-6。
- 血友病小鼠关节腔内注射融合蛋白减轻软骨损伤,但滑膜炎症几乎未受影响。
核心结论
- IL4-10融合蛋白在体外防止血液诱导的软骨损伤,在血友病小鼠中改善关节出血后的软骨退变。
研究设计与样本
- 体外研究使用人软骨外植体暴露于全血及不同浓度融合蛋白,并检测IL-1β和IL-6产生。
- 体内研究使用血友病A小鼠,评估关节腔内治疗对关节出血所致滑膜炎和软骨损伤的组织化学影响。
主要发现
- 体外融合蛋白呈剂量依赖性防止血液诱导的软骨损伤,效果与单独细胞因子联合相当。
- 全血培养中10 ng mL-1融合蛋白完全阻断单核/巨噬细胞产生IL-1β和IL-6。
- 血友病小鼠关节腔内注射IL-4和IL-10未影响滑膜炎或软骨退变。
- 等摩尔量融合蛋白减轻反复关节出血后的软骨损伤,但滑膜炎症几乎未受影响。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Essentials Targeted treatment for hemophilic arthropathy, still causing significant morbidity, is lacking. This study evaluates the efficacy of a fusion of protein of interleukin(IL)-4 and IL-10. In vitro the fusion protein prevents blood-induced cartilage damage in a dose-dependent manner. In hemophilic mice, the IL4-10 fusion protein ameliorates cartilage damage upon joint bleeding. SUMMARY: Background Joint damage still causes significant morbidity in hemophilia. It results from synovial inflammation and direct cartilage-degenerating properties of blood components. Interleukin (IL)-4 and IL-10 have been shown to protect cartilage from blood-induced damage. Recently an IL4-10 fusion protein has been developed to combine the function of IL-4 and IL-10 and increase their bioavailability. Objectives In this study we evaluate whether this IL4-10 fusion protein protects against blood-induced joint damage. Methods In vitro, human cartilage explants were exposed to whole blood and simultaneously to a broad concentration range of the IL4-10 fusion protein. Effects on cartilage matrix turnover were compared with the individual cytokines. Moreover, the influence of the fusion protein and its individual components on IL-1β and IL-6 production was investigated. In hemophilia A mice, the effect of intra-articular treatment on synovitis and cartilage damage resulting from joint bleeding was evaluated by histochemistry. Results In vitro, the fusion protein prevented blood-induced cartilage damage in a dose-dependent manner, with equal effectiveness to the combination of the separate cytokines. In whole blood cultures 10 ng mL-1 fusion protein completely blocked the production of IL-1β and IL-6 by monocytes/macrophages. In hemophilic mice, intra-articular injection of IL-4 and IL-10 did not influence synovitis or cartilage degeneration. In contrast, equimolar amounts of the fusion protein attenuated cartilage damage upon repeated joint bleeding, although synovial inflammation was hardly affected. Conclusions Overall, this study shows that the IL4-10 fusion protein prevents blood-induced cartilage damage in vitro and ameliorates cartilage degeneration upon joint bleeding in hemophilic mice.
引用
- van Vulpen LFD, Popov-Celeketic J, van Meegeren MER, et al. A fusion protein of interleukin-4 and interleukin-10 protects against blood-induced cartilage damage in vitro and in vivo. J Thromb Haemost. 2017. PMID: 28696534. doi:10.1111/jth.13778
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。